KENNETH J. RYAN, M.D.; ELIZABETH BARRETT-CONNOR, M.D.; DANIEL D. FEDERMAN, M.D.; GERALD A. GLOWACKI, M.D.; SAUL B. GUSBERG, M.D.; ELIZABETH D. JONES, M.S.W.; HOWARD L. JUDD, M.D.; WELDON G. KOLB, M.D.; STANLEY G. KORENMAN, M.D.; ANNE M. SEIDEN, M.D.; NOEL S. WEISS, M.D.; BARBARA S. HULKA, M.D.; ISAAC SCHIFF, M.D.; MILTON C. WEINSTEIN, PH.D.; B. LAWRENCE RIGGS, M.D.
This content is PDF only. Please click on the PDF icon to access.
A consensus development conference on Estrogen Use and Postmenopausal Women was held at the National Institutes of Health, 13-14 September 1979, to explore the risks and benefits of estrogen use. Among the subjects addressed were the benefits of estrogen use, including treatment for menopausal symptoms and possible prevention of osteoporosis; hazards of estrogen use; relative risks and benefits of various types of estrogen therapy; economic issues; and indications for and contraindications to estrogen use.
The consensus conclusions reached and presented here are based on the three position papers prepared for the conference, the response of the panel, and the general
RYAN KJ, BARRETT-CONNOR E, FEDERMAN DD, GLOWACKI GA, GUSBERG SB, JONES ED, et al. Estrogen Use and Postmenopausal Women: A National Institutes of Health Consensus Development Conference. Ann Intern Med. ;91:921–922. doi: 10.7326/0003-4819-91-6-921
Download citation file:
Published: Ann Intern Med. 1979;91(6):921-922.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use